June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Differentiation Potential of Limbal Fibroblasts and Bone Marrow Mesenchymal Stem Cells to Corneal Epithelial Cells
Author Affiliations & Notes
  • Kishore Reddy Katikireddy
    Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School., Boston, MA
  • Reza Dana
    Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School., Boston, MA
  • Ula Jurkunas
    Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School., Boston, MA
  • Footnotes
    Commercial Relationships Kishore Reddy Katikireddy, None; Reza Dana, Allergan (C), Alcon (C), Bausch & Lomb (C), Eleven Bio (I), GSK (F), Novabay (C), Revision Optics (C), Novaliq (C), RIgel (F); Ula Jurkunas, 61/482,769 (P), Altheos (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 981. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kishore Reddy Katikireddy, Reza Dana, Ula Jurkunas; Differentiation Potential of Limbal Fibroblasts and Bone Marrow Mesenchymal Stem Cells to Corneal Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 2013;54(15):981.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: It has been shown that human limbal fibroblasts (LFs) and bone marrow mesenchymal stem cells (BM MSCs) are multipotent. Specifically, a side population of stage-specific embryonic antigen-4 (SSEA4)-positive LFs differentiates into a variety of cell types. The present study compared the stem cell characteristics of SSEA4+ and SSEA4- LFs to those of BM MSCs, and determined their potential to differentiate into the corneal epithelial phenotype.

Methods: Human cadaveric limbal tissue (n=6) was treated with dispase to remove the epithelium and endothelium. Single cell suspensions were obtained by digesting the stroma with 0.025% trypsin. Stem cell enrichment was performed by exposure of BM MSCs and LF cells in KnockOut ESC/iPSC medium for 12-15 days. LF and BM MSCs were sorted for SSEA4+ and SSEA4- cells by Magnetic-Activated Cell Sorting. Cell doubling time (CDT), stem cell (SC) marker analysis, and colony forming efficacy (CFE) were performed on sorted LF and BM MSCs. Epithelial phenotype was achieved using induction and differentiation media. Differentiated cells were characterized for corneal cytokeratins (CKs).

Results: After separation, enriched LFs and BM MSCs, 97.4 ± 0.6% and 93.5 ± 0.7% SSEA4+ subgroups were achieved, respectively. The CDT of SSEA4+ LFs was 102 ± 1 hr and SSEA4- LFs was 58.2 ± 1.5 hrs (p=0.002). CDT of SSEA4+ BM MSCs was 105 ± 1 hr. and SSEA4- BM MSC was 56.3 ± 2 hrs (p=0.002). LF and BM MSC subgroups were negative for pan-cytokeratin. After enrichment, SSEA4+ cells showed the ability to form cell aggregates, while SSEA4- cells were mostly adherent to the culture plates. The transcript levels of SC markers OCT4, SOX2, Nanog and Rexo1 were higher in SSEA4+ than SSEA4- groups of LF and BM MSCs (p<0.05). Upon induction and differentiation, both SSEA4+ LFs and BM MSCs exhibited an epithelial morphology and positivity for CK3, CK12, and CK8, with high CFE (p<0.02), whereas the SSEA4- cells exhibited a fibroblast morphology and were negative for corneal epithelial markers.

Conclusions: Although both LFs and BM MSCs express stem cell markers and have some transdifferentiation potential, only SSEA4+ LFs clearly demonstrate the ability to differentiate into corneal epithelial cell phenotype. These findings establish a potential alternative source of corneal epithelial cells that can be harvested for ocular surface reconstruction.

Keywords: 721 stem cells • 482 cornea: epithelium • 500 differentiation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×